Dr. David Robert Shprecher, DO

Dr. Shprecher practices at Banner Alzheimer's Institute in Sun City, Arizona.

Dr. Shprecher's NPI, 1679692594, was assigned on March 29, 2007. Dr. Shprecher graduated from Lake Erie College of Osteopathic Medicine, Erie in 2003. Dr. Shprecher holds Arizona license 6821.

Dr. Shprecher's primary practice is Banner Alzheimer's Institute, at 10515 W Santa Fe Dr Bldg B 1st Floor Bldg B, Sun City, AZ 85351-3020. The practice phone is (623) 832-6530.

Dr. Shprecher's primary practice is Banner Alzheimer's Institute in Sun City, Arizona. Dr. Shprecher is also affiliated with Verde Valley Medical Center. The medical group on file is Banner Alzheimer's Institute. Dmand AI also links Dr. Shprecher to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shprecher practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Shprecher's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Shprecher's licenses on file in 3 states: Arizona, New York and Utah.

CMS data shows 11,429 Medicare services from Dr. Shprecher across 12 procedure codes in 2024, for 332 Medicare patients. Medicare paid $121,396 for them. Every service was in an office.

CMS counts 332 Medicare patients who saw Dr. Shprecher in 2024. The largest group is 75 to 84, with 160 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shprecher's median patient age at 73, with 48% women.

In 2024, Dr. Shprecher wrote 3,659 Medicare Part D claims for 493 patients. 82% of them were for generic drugs. CMS names the drug for 3,447 of them, across 55 drugs with 11 or more claims each, at $2,248,445 in total drug cost. In 2023, CMS named 3,010 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Shprecher for performance year 2024, reported as part of a group. Dr. Shprecher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shprecher as offering telehealth.

Dmand AI links 51 papers to Dr. Shprecher, published from 2012 to 2025. 2016 was the busiest year, with 6. The most frequent topics are Parkinson Disease, Alzheimer Disease and Lewy Body Disease. Dr. Shprecher has published most often in Mov Disord. Dr. Shprecher's most frequent co-authors are Charles H. Adler, MD, Shyamal H. Mehta, MD, PhD and Erika D. Driver-Dunckley, MD.

Dmand AI links Dr. Shprecher to 8 clinical trials, 5 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Parkinson Disease, Parkinsonian Disorders and Lewy Body Disease.

CMS Open Payments shows 979 general payments to Dr. Shprecher from 39 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $153,637. It also lists 12 research payments totaling $24,729 from 2016 to 2020.

Dr. Shprecher graduated from Lake Erie College of Osteopathic Medicine, Erie in 2003.